Category archives for: Industry News

FDA Approves Vosevi (sofosbuvir/velpatasvir/voxilaprevir) for Re-Treatment of Adults with Chronic Hepatitis C Virus

FOSTER CITY, Calif.–(BUSINESS WIRE)–Jul. 18, 2017– Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Vosevi (sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg) tablets, a…

Trump administration to continue paying cost sharing reductions

A day after President Donald Trump hinted he may let the insurance exchanges collapse, the White House says it will pay cost sharing reductions to help consumers afford coverage on the exchanges this month.

Women CEOs, nurses get short end of salaries

Women CEOs of hospitals earn 22% less than their male counterparts, and even male nurses earn more than female nurses, a panel of healthcare executives observed at the Modern Healthcare Women Leaders in Healthcare Conference.

UnitedHealth 2Q profit surges as ACA participation shrinks

UnitedHealth Group’s second-quarter earnings soared as the nation’s largest insurer dove deeper into government-funded health coverage like Medicare and Medicaid and continued to distance itself from the turbulent Affordable Care Act insurance…

FDA Approves Vosevi (sofosbuvir, velpatasvir and voxilaprevir) for Hepatitis C

July 18, 2017 — The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. Vosevi is a fixed-dose, combination tablet…

Memorial Hermann's Cordola tapped to lead Ascension Texas

Ascension Healthcare has selected Craig Cordola to replace Jesus Garza as its senior vice president and the ministry market executive of Ascension Texas effective Sept. 1, the Catholic-sponsored organization announced Tuesday.

Athenahealth CFO Stubelis heads to Arcadia Health Solutions

Karl Stubelis is leaving Athenahealth Friday after a little over a year as the EHR vendor’s CFO. He will be Arcadia Health Solutions’ new CFO and lead capital strategy for the company.

Grapefruit Juice and Some Drugs Don't Mix

Grapefruit juice can affect how well some medicines work, and it may cause dangerous side effects.

GOP health bill could spell doom for rural providers

Rural hospitals, already struggling after years of cuts to the growth of Medicare reimbursement, fear the plan to end Medicaid expansion and drop billions from the program would mean many would have to close their doors.

FDA Approves Nerlynx (neratinib) to Reduce the Risk of Breast Cancer Returning

July 17, 2017 — The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type of cancer, Nerlynx is the first extended adjuvant…

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us